EVR and EPO for Liver Transplant Tolerance

(

EVEREST

)

ITN Protocol #:

ITN101ST

Branded Name:

EVEREST

ClinicalTrials.Gov ID:

NCT06832189

Treatment Protocol #:

Therapeutic Area:

Transplantation

Current Status:

Enrollment

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

Everolimus and Epoetin for Sustained liver transplant Tolerance

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Clinical Trial Physician

NIAID Project Manager

NIAID Regulator Officer

Rho Scientist

Study Personnel:

Protocol Chair

Michele DesMarais mdesmarais@immunetolerance.org

Work:

415-420-4250

Protocol Chair

Geo Gaile ggaile@immunetolerance.org

Work:

415-854-7485

Protocol Chair

Cindy Breeden, MPH cbreeden@immunetolerance.org

Work:

404-379-5811

Protocol Chair

Sindhu Chandran, MD schandran@immunetolerance.org

Work:

415-610-4284

Protocol Chair

Jaclyn Evans jaclyn.evans@nih.gov

Work:

240-669-5470

Protocol Chair

Paul Price, PhD paul.price@nih.gov

Work:

301-761-7835

Admin Links

Shortcuts

ITN Documents

Links